title: Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.
abstract: The BD Phoenix system was evaluated for species-level identification of yeasts (250 clinical isolates) and compared with the Vitek 2 system, using ribosomal internal transcribed spacer (ITS) sequence analysis as the gold standard. Considering only the species included in each system's database, 96.3% (236/245) and 91.4% (224/245) of the isolates were correctly identified by BD Phoenix and Vitek 2, respectively.
authors: Institute of Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
authors: Brunella
authors: B
authors: Posteraro
authors: Alberto
authors: A
authors: Ruggeri
authors: Elena
authors: E
authors: De Carolis
authors: Riccardo
authors: R
authors: Torelli
authors: Antonietta
authors: A
authors: Vella
authors: Flavio
authors: F
authors: De Maio
authors: Walter
authors: W
authors: Ricciardi
authors: Patrizia
authors: P
authors: Posteraro
authors: Maurizio
authors: M
authors: Sanguinetti
mesh_terms: D006801:Humans; D008828:Microbiological Techniques / Q000379:methods*; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D009172:Mycology / Q000379:methods*; D009181:Mycoses / Q000175:diagnosis* / Q000382:microbiology*; D015003:Yeasts / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*
references: Int J Med Microbiol. 2011 Aug;301(6):531-5
references: 21570908
references: Crit Rev Microbiol. 2010;36(1):1-53
references: 20088682
references: Diagn Microbiol Infect Dis. 2012 May;73(1):45-8
references: 22578938
references: J Antimicrob Chemother. 2011 Oct;66(10):2315-22
references: 21795259
references: J Antimicrob Chemother. 2012 Nov;67(11):2739-48
references: 22868644
references: Crit Care Med. 2009 May;37(5):1612-8
references: 19325476
references: Int J Infect Dis. 2010 Nov;14(11):e954-66
references: 20797887
references: J Clin Microbiol. 2009 Apr;47(4):1216-7
references: 19193845
references: J Antimicrob Chemother. 2012 May;67(5):1181-7
references: 22351683
references: Expert Rev Proteomics. 2013 Apr;10(2):151-64
references: 23573782
references: Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6
references: 21930869
references: J Clin Microbiol. 2012 Nov;50(11):3435-42
references: 22875889
references: J Clin Microbiol. 2007 Apr;45(4):1343-6
references: 17287333
references: Clin Microbiol Infect. 2009 Jul;15(7):662-9
references: 19614718
references: J Med Microbiol. 2013 Jan;62(Pt 1):10-24
references: 23180477
references: Intensive Care Med. 2009 Jan;35(1):55-62
references: 18972101
references: J Clin Microbiol. 2011 Jul;49(7):2722-7
references: 21543578
references: Lancet Infect Dis. 2011 Feb;11(2):142-51
references: 21272794
references: J Clin Microbiol. 2011 Sep;49(9):3257-61
references: 21795509
references: Am J Med. 2012 Jan;125(1 Suppl):S14-24
references: 22196205
references: Curr Opin Crit Care. 2010 Oct;16(5):445-52
references: 20711075
references: Diagn Microbiol Infect Dis. 2012 Aug;73(4):293-300
references: 22789847
references: Mycopathologia. 2012 Oct;174(4):259-71
references: 22580756
references: Mediterr J Hematol Infect Dis. 2011;3(1):e2011002
references: 21625306
references: J Antimicrob Chemother. 2010 Jul;65(7):1460-5
references: 20430790
references: Expert Rev Anti Infect Ther. 2011 Nov;9(11):1067-75
references: 22029524
references: J Clin Microbiol. 2013 Jan;51(1):117-24
references: 23100350
references: Mycoses. 2011 Sep;54(5):e546-56
references: 21554423